SCHEMBL14880906

SCHEMBL14880906

CC1(C)c2ccccc2-c2cc3c(cc21)[nH]c1ccc(-c2ccc4c5ccccc5c5ccccc5c4c2)cc13

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.38
AHR P35869 1/20 0.37
KIF11 P52732 6/20 0.36
KDM4E B2RXH2 2/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CDK4 P11802 2/20 0.33
CCND1 P24385 2/20 0.33
PARP1 P09874 1/20 0.33
NPC1 O15118 1/20 0.32
TNKS2 Q9H2K2 3/20 0.31
ATM Q13315 1/20 0.31
TLR9 Q9NR96 1/20 0.31
TLR8 Q9NR97 1/20 0.31
TLR7 Q9NYK1 1/20 0.31
TNKS O95271 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17280981 0.95 PGR (0.38) PGRAHRKIF11KDM4EMAPT
SCHEMBL19041708 0.92 PDK2 (0.35) PGRAHRKIF11KDM4EMAPT
SCHEMBL781373 0.91 CDK4 (0.39) PGRAHRCDK4CCND1NPC1
SCHEMBL22106242 0.88 PDK2 (0.41) PGRAHRKIF11KDM4EMAPT
SCHEMBL18062320 0.88 AHR (0.42) PGRAHRKIF11KDM4EMAPT
SCHEMBL31680 0.86 AHR (0.52) PGRAHRKIF11KDM4EMAPT
SCHEMBL29506376 0.86 AHR (0.52) PGRAHRKIF11KDM4EMAPT
SCHEMBL802821 0.86 PGR (0.40) PGRAHRKIF11KDM4EMAPT
SCHEMBL14979109 0.85 CDK4 (0.39) PGRAHRCDK4CCND1NPC1
SCHEMBL13432985 0.85 AHR (0.43) PGRAHRKIF11KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9978957-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2018-05-22 US disclosed
US-9978957-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2018-05-22 US disclosed
EP-2768808-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-11-15 EP disclosed
EP-2768808-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-11-15 EP disclosed
US-20170018722-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-01-19 US disclosed
US-20170018722-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-01-19 US disclosed
US-9515266-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2016-12-06 US disclosed
US-9515266-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2016-12-06 US disclosed
US-20140275530-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2014-09-18 US disclosed
US-20140275530-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2014-09-18 US disclosed
EP-2768808-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2014-08-27 EP disclosed
WO-2013056776-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2013-04-25 WO disclosed
WO-2013056776-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2013-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170018722-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES EFNA1, TTI1, TERT PGR 1398/4885AHR 2964/4885KIF11 1719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.